







Health care progress, antibiotics, vaccination and 
improving life standards caused a dramatic increase in 
lifespan in recent decades. By 2050, almost 40% of the 
European and US population is predicted to be >60 
years old [1]. This development raises global public and 
scientific interest in studying age-related diseases and in 
developing strategies to improve the elderly quality of 
life. A major age-related health issue is the increasing 
prevalence and severity of infectious diseases, which 
are the fourth most common cause of death in the 
elderly [2]. Vaccination has only limited success since 
aging is also associated with poor protective antibody 
response to vaccines. For example, seroprotection 
against influenza virus strains is only 29-46% in persons 
aged ≥75 years and 41%-58% in persons 60-74 years 
old [3]. Clinical attempts to enhance vaccination 
efficacy in the elderly based on improving antigen 
delivery [3-5] have yielded limited success, and other 
attempts to regenerate the immune system in aging 
through dietary intake yielded very questionable 
benefits [6]. Such insufficient progress justifies 
development of new innovative approaches to enhance 
immunity in aging. However, to facilitate this, better 
understanding of immunosenescence mechanisms is 
necessary. In the present perspective we discuss our 




























Immunosenescence of the B lineage 
 
The poor ability to mount protective antibody responses 
in aging is primarily the outcome of dramatic alterations 
in the composition of B cell compartments, and the 
inefficient functional responsiveness of the peripheral 
pool. In mice, follicular B cell number drops with age, 
and the relative proportion of the antigen-experienced 
fraction increases [7,8]. Thus, the diverse, young-like 
peripheral repertoire gradually becomes limited in aging 
[9-11], thereby lacking the naïve cells that are able to 
recognize and respond to new antigens. Nevertheless, 
the total number of B cells in aged mice remains 
unchanged [8,12]. 
 
Age-associated changes in the composition of 
peripheral B cells reflect both increased B cell longevity 
and decreased B cell generation in the bone marrow 
(BM) [12]. Reduced B cell generation in the aged BM is 
due to many reasons, including reduced B cell 
progenitor frequencies [13] and proliferative potential 
[14], decreased IL-7 production [15] and impaired V-DJ 
rearrangement [16]. The latter appears to result not from 
a reduction in recombination-activating gene expression 
but from changes in the expression of the E2A-encoded, 
E12 and E47 basic helix-loop-helix proteins that           
bind the IgH promoter [17]. In addition, defects in 
hematopoietic stem cells (HSCs) that influence B 
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epigenetic modifications [21]; skewing of lineage 
potential from lymphopoiesis towards myelopoiesis 
[22-24]; altered development in the BM [25] and failure 
to generate a naïve young-like B cell repertoire [26]. 
 
In the periphery, the extended survival of memory cells, 
homeostatic proliferation and clonal expansion 
contribute to the limited repertoire and the poor 
antibody response in aging [27-30]. Additional intrinsic 
defects found in the response of B cells from aged mice 
or humans include decreased CSR and expression of 
activation induced cytidine deaminase (AID) and E47 
[31], reduced activation and expression of phosphor-
tyrosine kinases and protein kinase C [32], decreased 
expansion of B cells in response to antigen [33], and 
reduced number and volume of  germinal centers (GCs) 
[34]. In collaboration with the Dunn-Walters group 
[35], we studied Ig genes from GC B cells to elucidate 
which factors in the affinity maturation process change 
with age. Age-related changes in the pattern of 
hypermutation were seen, although the analysis of 
variable region heavy chain (VH) genes and their 
lineage trees shows that an alteration in the mechanism 
of somatic hypermutation is unlikely. The changes are 
due to founder cell effects and/or the process of 
selection. Striking tissue-specific differences were seen. 
All measurements indicated that selection of Ig genes 
may decrease in Peyer’s patch GC but increase in 
splenic GC with age. These tissue-specific differences 
highlight the importance of considering the activation 
and effector sites when studying immune senescence. 
All these factors contribute to the reduced quality of the 
antibody response as measured by amount and affinity 
(reviewed in [29]). 
 
Several attempts to reverse the immunosenescent 
phenotype of the B lineage based on modification of 
gene expression were performed. It has been shown that 
the expression of p16Ink4a and Arf, which are products 
of the Cdkn2a tumor suppressor locus that are involved 
in cell cycle regulation and used as molecular signatures 
of aging in rodent and human tissues [36], is 
significantly increased in all stages of B lymphopoiesis 
in old mice, particularly in pro-B and pre-B cells. 
Down-regulation of these genes, obtained by deletion of 
the Bmi-1 repressor or by shRNA, reverted the 
senescent phenotype in aged lymphoid progenitors and 
restored their proliferative defects [37]. A more recent 
study used a retroviral vector to restore E47 expression 
in splenic B cells from old mice. This treatment rescued 
some of the intrinsic age-related defects as revealed by 
up-regulation of AID and CSR and the improved B cell 
immune responses in senescent murine B cells. 
 
Homeostasis in B lymphopoiesis 
 
Homeostatic pressures play critical role in 
hematopoiesis and fit well within the concept in which 
early cell lineages adapt their output to demand [38,39]. 
There are several examples where homeostatic 
regulation mechanisms do not substantially change with 
aging, such as red blood cell production during 
physiological and pathological changes [39], myeloid 
progenitor number and developmental potential [23, 
40], proliferation and mobilization of stem cells in 
response to G-CSF [41], and the ability of BM 
precursors to generate well-functioning CD4 T cells in 
mice [42]. 
 
Homeostasis in the hematopoietic system is studied by 
Bromodeoxyuridine (BrdU)-labeling experiments to 
assess the degree of proliferation of newly generated 
cells. Over the years these studies evoked a large 
controversy on the production rates, division rates, and 
lifespans of mouse and human lymphocyte populations, 
leaving fundamental questions such as the maintenance 
of memory, the maintenance of a diverse naive 
lymphocyte repertoire, and the nature of homeostatic 
mechanisms largely unresolved [43]. Mathematical 
models have been used to extract parameters from 
labeling experiments for better interpretations of the 
results, which otherwise are very often misinterpreted. 
For example, we have used the combination of BrdU 
labeling and mathematical models to study the 
development and maturation of T cells [44, 45], B cells 
[25, 46] and NK cells (Elemans et al., manuscript in 
preparation). These studies led to the discoveries of 
feedbacks in T cell development [47], blind homeostasis 
in peripheral T cell populations [48], and phenotypic 
reflux in B cell development [25]. Using similar 
labeling experiments in young/adults mice, it has been 
calculated that out of the 1-2x107 immature B cells that 
are generated daily in the BM, only 3% enter the pool of 
mature B cells [49, 50]. Several experimental 
approaches to determine the life span of the mature B 
cells reached different estimates ranging from 3-4 days 
to several weeks or months [51-53]. A more recent 
study used conditional gene targeting to ablate B 
lymphopoiesis in the BM in order to determine the life 
span of B cells in the absence of B cell influx from the 
BM. This study concluded that naïve follicular B cells 
have half life of ~4.5 months [54]. Thus, in young 
animals, B cell output from the BM and the size of the 
peripheral compartment are regulated by homeostatic 
pressures and physiological adjustments that are set by 
competition for trophic resources such as BAFF [27] 
and for survival niches [55]. Once these resources 
become   limited,    steady   state   B  cell   numbers   are  
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and loss rates [27]. However, the attempts to determine 
whether B lymphopoiesis is regulated by homeostatic 
pressures imposed by the peripheral B cell compartment 
have reached to contradicting conclusions. Thus, Park 
and Osmond [56,57] and Cancro and Allman [58] 
demonstrated homeostatic regulation, whereas Freitas 
and colleagues [59] suggested that B cell production in 
the BM is autonomously regulated.  
 
The above conclusions, however, may not be applicable 
to the B lineage in aging, where it undergoes dramatic 
alterations in the cellular composition [8,11,13]. Early 
studies have shown that BM or purified HSCs from old 
mice failed to reconstitute the peripheral B cell 
compartment upon short-term of B cell ablation by 
cyclophosphamide or in BM chimeras [8,26,60], 
thereby supporting the argument that age-related 
changes in B lymphopoiesis are not the consequence of 
homeostatic regulations. More recent studies, however, 
proposed that HSCs in aging subjects have a different 
clonal composition with decreased lymphoid-biased 
HSCs [24,61], which could explain the inefficient B 
lineage reconstitution in the above studies. The finding 
that an increasing dose of old HSCs for reconstitution 
partially restores age-associated changes in the BM and 
in the periphery [26] supports this hypothesis. 
 
Using the combination of BrdU labeling and 
mathematical modeling, we investigated the changes in 
B cell development during aging [14]. Our results point 
at a reduction of pro-B/pre-B proliferative capacity after 
passing the first rearrangement checkpoint, similar to 
what we have found in T cells [62]. In addition, they 
suggest a possible reduction of the number or quality of 
survival niches for the developing B lymphocytes, as 
the carrying capacity of the pre-B cell compartment was 
found to be significantly reduced in aging [13,40]. This 
effect may be related to the accumulation of 
recirculating B cells in the bone marrow with aging, as 
we have also found that the number of "static" (non-
dividing) IgM+ B cells in the bone marrow increases 
with age, and thus effectively reduces even further the 
space available for the developing B cells. 
 
Reactivation of B lymphopoiesis in aging 
 
In an attempt to find whether suppression of B 
lymphopoiesis in aging reflects homeostatic pressures, 
we adopted two experimental approaches allowing us to 
alter B cell homeostasis in old mice via B cell depletion. 
In these experiments, we examined the two alternative 
possibilities: 1) B cell lymphopoiesis will remain 
suppressed, implying that suppression of B lympho-
poiesis with aging is due to progressive and irreversible 
changes in HSCs, as suggested [23,26,60]; or 2) B cell 
lymphopoiesis will be reactivated, implying that the 
age-related suppression is due to homeostatic regulation 
that can be reversed. Our first approach was based on a 
genetic setting allowing the inducible ablation of the 
BAFF-receptor (BAFF-R) gene and the consequential 
deletion of peripheral B cells, since BAFF-BAFF-R 
signaling is critical for survival of mature B cells [63]. 
Our second approach was based on antibody-mediated 
B cell depletion in wild-type mice, which is similar to 
the approach used in lymphoma and rheumatoid 
arthritis patients treated with rituximab [64]. The 
outcome of both approaches is the establishment of 
long-term, chronic B cell deficiency in vivo. The results 
we obtained conclusively indicated that suppression of 
B lymphopoiesis in aging reflects homeostatic pressures 
in the B lineage [65]. In both models we observed a 
revival of B lymphopoiesis after depletion, as reflected 
by both frequencies and absolute numbers of pro-, pre- 
and immature B cells in the BM of the old-treated mice. 
We further addressed whether these homeostatic 
changes are sensed by earlier BM progenitors. Indeed, 
we found that upon chronic B cell deficiency, 
frequencies of multipotent primitive progenitors (MPPs) 
and common lymphoid progenitors (CLPs) were 
significantly increased, thereby to support the reacti-
vation of B lymphopoiesis. The expansion of these 
progenitors argues that the reported age-related changes 
in HSCs must be reversible. There are several possible 
explanations for reversing the age-related defects in 
HSCs, as follows. 1) The acquisition of defects in HSCs 
is regulated by the peripheral demands for B-cell. For 
example, a decreased demand for B cell production in 
aged mice due the accumulation of long-lived cells may 
lead to selection of slow cycling HSCs, whereas a 
chronic demand for B cells enforces continuous B cell 
production and this may select for rapid cycling HSCs. 
2) HSCs are capable of clearing the accumulated defects 
to reverse cellular senescence. Since environmental 
factors [19] and epigenetic modifications [21] affect the 
entrance into cellular senescence, these changes may be 
reversible. Studies showing that aged skeletal stem cells 
exposed to factors present in young serum restore their 
proliferation and regenerative capacity [66] support this 
possibility. 3) A low frequency of unmutated HSCs 
exists in the old BM and are selected to expand and 
differentiate into B lineage cells upon B cell depletion. 
This implies that reactivation of B lymphopoiesis does 
not occur rapidly to allow expansion of lymphoid 
progenitors, thereby explaining the failure of BM cells 
from old mice to rapidly reconstitute the B lineage in 
BM chimera or after lymphoablation [26,60]. Moreover, 
this possibility is supported by studies proposing that 
age-related alterations in the B lineage reflect changes 
in the clonal composition of  the  HSCs [24] or  dictated  
   























by clonal expansion of functionally distinct HSC 
population [61], and the identification of a 
subpopulation of HSCs in the BM of old mice that 
retains an equivalent potential to differentiate into 
lymphoid and myeloid lineages [61]. 
 
The depletion of B cells and reactivation of B 
lymphopoiesis has rejuvenated the peripheral 
compartment. We showed that the long-lived antigen-
experienced B cell compartments had been replaced by 
newly generated cells. These processes had also 
restored the "young-like" peripheral repertoire, but this 
has only been demonstrated using a repertoire-reporting 
immunoglobulin transgenic mouse model. Thus, further 
repertoire studies in normal old mice are necessary to 
validate this. However, the ability to rejuvenate the 
peripheral compartment by depletion of B cells is 
supported by studies showing that in patients treated 
with Rituximab, which depletes patients of B cells, the 
reconstituting B cells express a young phenotype [64] 
and a diverse repertoire [67]. A major question that 
arises in light of these findings is whether the 
rejuvenated B cells can mount enhanced immune 
response. Indeed, we found that upon administration of 
a foreign antigen, old mice that have rejuvenated their 
peripheral B cell compartment mounted a significantly 
enhanced antibody response relative to that of untreated 
age-matched mice. Yet, the response was still greatly 
reduced relative to the young controls, but this might be 
due to the age-related defects in the T lineage and in 

























Conclusions and future directions 
 
The major conclusion of our study is that age-related 
alterations in the B lineage are reversible and mediated 
by homeostatic pressures imposed by the long-lived B 
cells accumulating in the periphery with age (figure 1). 
These observations are the foundations of new 
paradigms for enhancing immune responsiveness in 
aging, which may be translated in the future for clinical 
use. The nature of these homeostatic regulation 
mechanisms and the cross-talk between peripheral B 
cells and progenitor cell populations in the BM are yet 
to be identified. This will allow direct manipulation of 
B cell homeostasis by targeting the regulatory factor(s) 
rather than by depletion of B cells, to reactivate B 
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equilibrium  by  depletion  of  B  cells  in  old  mice,  increases  frequencies  of  lymphoid‐committed  stem  cells  to  reactivate  B 
lymphopoiesis  and  to  increase  B  cell  output  from  the  BM  to  the  periphery.  The  nature  of  these  cross‐talk  homeostasis 
mechanisms is yet to be defined, but our results suggest that they are sensed by the stem cell compartments. 
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